Head office

of the international specialised pharmaceutical corporation "YURiA-PHARM" Ltd.
10 Amosova Str., Kyiv, 03038, Ukraine
+38(044)246-83-83; +38(044)275-01-08


You are asked to report any information on the side effects or lack of efficacy of Tivortin Aspartate that comes to your notice using the adverse drug reaction reporting form. All information you give us will be kept strictly confidential and will not be disclosed except as provided by law.